Prior to publication of the final evidence report, EPCs sought input from independent Peer Reviewers without financial conflicts of interest. However, the conclusions and synthesis of the scientific literature presented in this report do not necessarily represent the views of individual reviewers. AHRQ may also seek comments from other Federal agencies when appropriate.

Peer Reviewers must disclose any financial conflicts of interest greater than $5,000 and any other relevant business or professional conflicts of interest. Because of their unique clinical or content expertise, individuals with potential nonfinancial conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any potential nonfinancial conflicts of interest identified.

The list of Peer Reviewers follows:

• Daniel A. Mulrooney, M.D., M.S.
  Associate Member
  Departments of Oncology and Epidemiology and Cancer Control
  St. Jude Children’s Research Hospital
  Memphis, TN
• Lisa A. Schwartz, Ph.D.
  Psychologist, Division of Oncology
  The Children’s Hospital of Philadelphia
  Associate Professor, Department of Pediatrics
  Perelman School of Medicine, University of Pennsylvania
  Philadelphia, PA
• Dava Szalda, M.D., M.S.H.P.
  Program Director, Internal Medicine Pediatrics Residency Program
  Co-Director, Adult Care and Transition Team
  Cancer Survivorship Program Physician
  Children’s Hospital of Philadelphia
  Hospital of the University of Pennsylvania
  Philadelphia, PA